1. Biologics with Patent Expiries within 10 years:
Patent Expiry 2013
Neupogen
Betaseron
Humulin
Novolin
Pulmozyme
Intron A
Infergen
HGH
2014
Remicade
Leukine
2015
Epogen
Aranesp
Rituxan
Avonex
Humalog
Novalog
Rebif
Cerezyme
2016
Enbrel
Erbitux
2017
Avastin
Synagis
Tsyabri
Herceptin
Lantus
Neulasta
Kineret
Fabrazyme
Follistim/Gonal-F
You will biosimilars listed at www.genericlicensing.com when available